Literature DB >> 2734316

Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis.

R T Holman1, S B Johnson, E Kokmen.   

Abstract

Fatty acid compositions of plasma phospholipids, cholesteryl esters, triacylglycerols, and nonesterified fatty acids of 14 clinically proven and graded cases of multiple sclerosis were determined by capillary gas chromatography and compared with the values obtained for 100 normal, healthy subjects. In phospholipids, linoleic acid (18:2 omega 6; 18 carbon atoms, 2 double bonds, 6 carbon atoms beyond last double bond) was normal and 18:3 omega 6 was increased, but all subsequent omega 6 acids were subnormal (P less than 0.001), indicating impairment of chain elongation. All omega 3 acids were subnormal. The paucity of polyunsaturated fatty acids was compensated mass-wise by an increase in saturated acids. Disproportionate increases in short-chain, saturated, and monounsaturated acids, decreases in long-chain homologs, and increases of branched and odd-chain acids were observed. Loss of polyunsaturated fatty acids and replacement by nonessential acids lowered mean chain length and raised mean melting point significantly, suggesting that lowered membrane fluidity was only partially compensated by endogenous synthesis of lower-melting, nonessential acids. This phenomenon was not observed in cholesteryl esters or triacylglycerols. Nonesterified fatty acids showed significant changes in pattern of possible autacoid precursors. The abnormal profile of fatty acids in multiple sclerosis has features in common with profiles of other syndromes involving viral infections.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2734316      PMCID: PMC287343          DOI: 10.1073/pnas.86.12.4720

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  NUTRITIONAL AND METABOLIC INTERRELATIONSHIPS BETWEEN FATTY ACIDS.

Authors:  R T HOLMAN
Journal:  Fed Proc       Date:  1964 Sep-Oct

2.  Fatty acids in spinal fluid and serum of patients with demyelinating disorders.

Authors:  N TUNA; J LOGOTHETIS; R KAMMERECK
Journal:  Neurology       Date:  1963-05       Impact factor: 9.910

3.  Major plasma lipids and their fatty acid composition in multiple sclerosis and other neurological diseases.

Authors:  I Karlsson; C Alling; L Svennerholm
Journal:  Acta Neurol Scand       Date:  1971       Impact factor: 3.209

4.  Competitive inhibitions in the metabolism of polyunsaturated fatty acids studied via the composition of phospholipids, triglycerides and cholesteryl esters of rat tissues.

Authors:  P T Garcia; R T Holman
Journal:  J Am Oil Chem Soc       Date:  1965-12       Impact factor: 1.849

5.  A biochemical approach to the problem of multiple sclerosis.

Authors:  R H Thompson
Journal:  Proc R Soc Med       Date:  1966-03

6.  Amplification and molecular cloning of HTLV-I sequences from DNA of multiple sclerosis patients.

Authors:  E P Reddy; M Sandberg-Wollheim; R V Mettus; P E Ray; E DeFreitas; H Koprowski
Journal:  Science       Date:  1989-01-27       Impact factor: 47.728

Review 7.  Linoleate and fatty acid compositions in the serum lipids of Japanese patients with multiple sclerosis.

Authors:  M Yoshida; S Takase; K Itahara; T Nakanishi
Journal:  Acta Neurol Scand       Date:  1983-11       Impact factor: 3.209

8.  The ratio of trienoic: tetraenoic acids in tissue lipids as a measure of essential fatty acid requirement.

Authors:  R T Holman
Journal:  J Nutr       Date:  1960-03       Impact factor: 4.798

9.  Abnormal polyunsaturated fatty acid patterns of serum lipids in alcoholism and cirrhosis: arachidonic acid deficiency in cirrhosis.

Authors:  S B Johnson; E Gordon; C McClain; G Low; R T Holman
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

10.  A new hepato-pancreato-renal disorder resembling tyrosinemia involving neuropathy and abnormal metabolism of polyunsaturated acids.

Authors:  H L Sharp; J A Lindahl; D K Freese; B Burke; J Englund; D Johnson; S B Johnson; R T Holman
Journal:  J Pediatr Gastroenterol Nutr       Date:  1988 Mar-Apr       Impact factor: 2.839

View more
  34 in total

1.  The composition of saturated fatty acids in plasma phospholipids changes in a way to counteract changes in the mean melting point during pregnancy.

Authors:  S R De Vriese; A C Houwelingen; G Hornstra; M Dhont; A B Christophe
Journal:  Lipids       Date:  2001-01       Impact factor: 1.880

2.  The effect of maternal diets on the mean melting points of human milk fatty acid.

Authors:  R G Jensen; S Patton
Journal:  Lipids       Date:  2000-10       Impact factor: 1.880

3.  Ether lipid composition and molecular species alterations in carp brain (Cyprinus carpio L.) during normoxic temperature acclimation.

Authors:  Y K Yeo; E J Park; C W Lee; H T Joo; T Farkas
Journal:  Neurochem Res       Date:  1997-10       Impact factor: 3.996

Review 4.  Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis.

Authors:  Insha Zahoor; Shailendra Giri
Journal:  Clin Rev Allergy Immunol       Date:  2021-04       Impact factor: 8.667

5.  Deficiency of essential fatty acids and membrane fluidity during pregnancy and lactation.

Authors:  R T Holman; S B Johnson; P L Ogburn
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

6.  Monounsaturated fatty acids in blood cell membranes from patients with multiple sclerosis.

Authors:  Gloudina Maria Hon; Mogamat Shafick Hassan; Susan Janse van Rensburg; Stefan Abel; Rajiv T Erasmus; Tandi Matsha
Journal:  Inflammation       Date:  2011-12       Impact factor: 4.092

7.  Erythrocyte membrane fatty acids in multiple sclerosis patients and hot-nature dietary intervention with co-supplemented hemp-seed and evening-primrose oils.

Authors:  Soheila Rezapour-Firouzi; Seyed Rafie Arefhosseini; Mehrangiz Ebrahimi-Mamaghani; Mehdi Farhoudi; Behzad Baradaran; Torbati Mohammad Ali; Fatemeh Zamani
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-10-03

8.  Omega-3 fatty acids and multiple sclerosis: relationship to depression.

Authors:  Robin L Aupperle; Douglas R Denney; Sharon G Lynch; Susan E Carlson; Debra K Sullivan
Journal:  J Behav Med       Date:  2008-04

9.  Serum fatty acid profiles in cystic fibrosis patients and their parents.

Authors:  A B Christophe; W J Warwick; R T Holman
Journal:  Lipids       Date:  1994-08       Impact factor: 1.880

10.  Membrane saturated fatty acids and disease progression in multiple sclerosis patients.

Authors:  G M Hon; M S Hassan; S J van Rensburg; S Abel; R T Erasmus; T Matsha
Journal:  Metab Brain Dis       Date:  2009-11-05       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.